Literature DB >> 23308051

c-Myc suppression of DNA double-strand break repair.

Zhaozhong Li1, Taofeek K Owonikoko, Shi-Yong Sun, Suresh S Ramalingam, Paul W Doetsch, Zhi-Qiang Xiao, Fadlo R Khuri, Walter J Curran, Xingming Deng.   

Abstract

c-Myc is a transcriptional factor that functions as a central regulator of cell growth, proliferation, and apoptosis. Overexpression of c-Myc also enhances DNA double-strand breaks (DSBs), genetic instability, and tumorigenesis. However, the mechanism(s) involved remains elusive. Here, we discovered that γ-ray ionizing radiation-induced DSBs promote c-Myc to form foci and to co-localize with γ-H2AX. Conditional expression of c-Myc in HO15.19 c-Myc null cells using the Tet-Off/Tet-On inducible system results in down-regulation of Ku DNA binding and suppressed activities of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and DNA end-joining, leading to inhibition of DSB repair and enhanced chromosomal and chromatid breaks. Expression of c-Myc reduces both signal and coding joins with decreased fidelity during V(D)J recombination. Mechanistically, c-Myc directly interacts with Ku70 protein through its Myc box II (MBII) domain. Removal of the MBII domain from c-Myc abrogates its inhibitory effects on Ku DNA binding, DNA-PKcs, and DNA end-joining activities, which results in loss of c-Myc's ability to block DSB repair and V(D)J recombination. Interestingly, c-Myc directly disrupts the Ku/DNA-PKcs complex in vitro and in vivo. Thus, c-Myc suppression of DSB repair and V(D)J recombination may occur through inhibition of the nonhomologous end-joining pathway, which provides insight into the mechanism of c-Myc in the development of tumors through promotion of genomic instability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23308051      PMCID: PMC3540944          DOI: 10.1593/neo.121258

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  61 in total

1.  Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression.

Authors:  Asa Karlsson; Debabrita Deb-Basu; Athena Cherry; Stephanie Turner; James Ford; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

2.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.

Authors:  Raju V Pusapati; Robert J Rounbehler; SungKi Hong; John T Powers; Mingshan Yan; Kaoru Kiguchi; Mark J McArthur; Paul K Wong; David G Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  DNA end-joining: from yeast to man.

Authors:  S E Critchlow; S P Jackson
Journal:  Trends Biochem Sci       Date:  1998-10       Impact factor: 13.807

4.  c-Myc overexpression uncouples DNA replication from mitosis.

Authors:  Q Li; C V Dang
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

5.  Protein-protein and protein-DNA interaction regions within the DNA end-binding protein Ku70-Ku86.

Authors:  X Wu; M R Lieber
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

6.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

7.  Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.

Authors:  Arkady Celeste; Oscar Fernandez-Capetillo; Michael J Kruhlak; Duane R Pilch; David W Staudt; Alicia Lee; Robert F Bonner; William M Bonner; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2003-07       Impact factor: 28.824

8.  Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.

Authors:  Koji Hironaka; Valentina M Factor; Diego F Calvisi; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

9.  c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.

Authors:  André O von Bueren; Christoph Oehler; Tarek Shalaby; Katja von Hoff; Martin Pruschy; Burkhardt Seifert; Nicolas U Gerber; Monika Warmuth-Metz; Duncan Stearns; Charles G Eberhart; Rolf D Kortmann; Stefan Rutkowski; Michael A Grotzer
Journal:  BMC Cancer       Date:  2011-02-16       Impact factor: 4.430

10.  Megabase chromatin domains involved in DNA double-strand breaks in vivo.

Authors:  E P Rogakou; C Boon; C Redon; W M Bonner
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

View more
  29 in total

1.  The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity.

Authors:  Fengmei Cui; Rong Fan; Qiu Chen; Yongming He; Man Song; Zengfu Shang; Shimeng Zhang; Wei Zhu; Jianping Cao; Hua Guan; Ping-Kun Zhou
Journal:  Mol Cell Biochem       Date:  2015-06-07       Impact factor: 3.396

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.

Authors:  B Wang; M Xie; R Li; T K Owonikoko; S S Ramalingam; F R Khuri; W J Curran; Y Wang; X Deng
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

4.  Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.

Authors:  Rosa Murria Estal; Sarai Palanca Suela; Inmaculada de Juan Jiménez; Cristina Alenda Gonzalez; Cecilia Egoavil Rojas; Zaida García-Casado; Jose Antonio López Guerrero; María José Juan Fita; Ana Beatriz Sánchez Heras; Ángel Segura Huerta; Ana Santaballa Bertrán; Isabel Chirivella González; Marta Llop García; Gema Pérez Simó; Eva Barragán González; Pascual Bolufer Gilabert
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

5.  Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage.

Authors:  Qing-qing Zhang; Wen-juan Wang; Jun Li; Neng Yang; Gang Chen; Zhong Wang; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2015-06-22       Impact factor: 6.150

6.  Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.

Authors:  Rosa Murria; Sarai Palanca; Inmaculada de Juan; Cristina Alenda; Cecilia Egoavil; Francisco J Seguí; Zaida García-Casado; María J Juan; Ana B Sánchez; Ángel Segura; Ana Santaballa; Isabel Chirivella; Marta Llop; Gema Pérez; Eva Barragán; Dolores Salas; Pascual Bolufer
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

7.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

Review 8.  c-MYC-induced genomic instability.

Authors:  Alexandra Kuzyk; Sabine Mai
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

9.  ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4.

Authors:  M Pieraccioli; S Nicolai; A Antonov; J Somers; M Malewicz; G Melino; G Raschellà
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

Review 10.  Combining Radiation Therapy with ALK Inhibitors in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer (NSCLC): A Clinical and Preclinical Overview.

Authors:  Delphine Antoni; Hélène Burckel; Georges Noel
Journal:  Cancers (Basel)       Date:  2021-05-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.